Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Shock (Augusta, Ga.)|May 5, 2017
The Reversal of Direct Oral Anticoagulants in Animal ModelsMarkus Honickel, Necib Akman, Oliver Grottke
Thrombosis and Haemostasis|January 9, 2015
Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumabMarkus Honickel, Stefanie Treutler, Joanne van Ryn, et al.
Journal of Clinical Medicine|December 1, 2020
Sufficient Thrombin Generation Despite 95% Hemodilution: An In Vitro Experimental StudyJohannes Gratz, Christoph J Schlimp, Markus Honickel, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 15, 2015
Twelve Hours In Vitro Biocompatibility Testing of Membrane OxygenatorsChristian Bleilevens, Oliver Grottke, Sabine Tillmann, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 15, 2018
The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran EliminationStephan Glund, Guanfa Gan, Viktoria Moschetti, et al.
British Journal of Anaesthesia|June 17, 2019
Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma modelOliver Grottke, Till Braunschweig, Rolf Rossaint, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 4, 2016
Septic porcine blood does not further activate coagulation during in vitro membrane oxygenationChristian Bleilevens, Oliver Grottke, Sabine Groening, et al.
Pageof 2